The global Molecular Infectious Disease Testing market, valued at US$8.49 billion in 2023, is forecasted to grow at a robust CAGR of 13.7%, reaching US$9.37 billion in 2024 and an impressive US$17.78 ...

Cancer cells have special adaptation mechanisms that allow them to proliferate despite changes in their genetic makeup.

Pacific Biosciences of California, Inc. ( NASDAQ: PACB) Q4 2024 Earnings Conference Call February 13, 2025 4:30 PM ET Todd Friedman - Senior Director, Finance and Investor Relations Christian Henry - ...

AI-based early warning and wildlife movement tracking systems are helping in mitigating the man-animal conflict in areas ...

Dundee Precious Metals Inc. (TSX: DPM) (“DPM” or the “Company”) announced its operating and financial results for the quarter and year ended December ...

Anti-Microbial/Anti-Fungal Tests MarketThe global anti-microbial/anti-fungal tests market is poised for significant growth, ...

Cancer cells have special adaptation mechanisms that allow them to proliferate despite changes in their genetic makeup.

GenomOncology, a precision medicine software company, and Pillar Biosciences, a leader in Decision Medicine™, today announced ...

Guardant Health is overcoming skepticism with new cancer tests. Learn why GH stock is a buy, with strong growth and a shift ...

Quantum-Si is sponsoring and moderating the panel event "Breaking Boundaries: How Next-Generation Protein Sequencing™ is ...